APOE Gene Alzheimer's Disease clinical trials
9 active Alzheimer's Disease trials that test for APOE Gene in their eligibility criteria. Describe your situation to see which ones you may be eligible for.
- Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
- Stem Cell Therapy for Early Alzheimer's Disease
- Predicting Pre-dementia
- Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- A Nutritional Intervention for Body, Brain, and Longevity Effects (NIBBLE)
- BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers
- GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype
- Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
- Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease
← All Alzheimer's Disease trials
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.